Mammaglobin B/SCGB2A1 Protein, Human, Recombinant (hFc)
Product Specifications
Bioactivity
SCGB2A1 represented a novel, prognostic factor for CRC, and that expression of SCGB2A1 correlated with chemoresistance, radioresistance and cancer cell stemness. SCGB2A1 is a top differentially expressed gene in all major histological types of ovarian cancers and may represent a novel and attractive target for the immunotherapy of patients harbouring recurrent disease resistant to chemotherapy.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-41664M-BF594 100 µL
VEGFA/VEGF165 Monoclonal Antibody, AbBy Fluor™ 594 Conjugated
Ask
View Details